Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subtle Ultrasound Atrial Anomalies Predicts the Early Diagnosis of Silent Atrial Fibrillation Detected by Implantable Cardiac Monitor in Patients With Cryptogenic Stroke. A Randomized Trial

NCT06542770 is registered in ClinicalTrials.gov with Parc de Salut Mar as lead sponsor.

NCT NCT06542770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06542770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subtle Ultrasound Atrial Anomalies Predicts the Early Diagnosis of Silent Atrial Fibrillation Detected by Implantable Cardiac Monitor in Patients With Cryptogenic Stroke. A Randomized Trial
Lead sponsor
Parc de Salut Mar
Phase
Not applicable
Overall status
Recruiting
Start date
January 1, 2021
Completion date
December 31, 2024
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac rhythm disorder, cryptogenic stroke, left atrial dilatation, paroxysmal atrial fibrillation